Whole-abdomen radiation therapy as salvage treatment for epithelial ovarian carcinoma

Cancer Journal from Scientific American

Volumn 3, Issue 6, 1997, Pages 358-363

  Sedlacek, Thomas V ^a   Spyropoulus, Pericles ^a   Cifaldi, Ralph ^a   Glassburn, John ^a   Fisher, Scot ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

Ovarian cancer; Radiation therapy; Salvage treatment

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ABDOMINAL RADIOTHERAPY; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT FAILURE;

ABDOMEN; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPITHELIUM; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; SALVAGE THERAPY;

EID: 0031457125     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Berek JS, Hacker NF, Lagasse LD et al. Second look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status. Obstet Gynecol 1984;64:207.
2. Sutton GP, Blessing JA, Homesley HD et al. Phase two trial of ifosfamide and mesna in advanced ovarian carcinoma: a gynecologic oncology group study. J Clin Oncol 1989;17:1672.
3. McGuire WP, Rowinsky EK, Rosenshein NB et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989;111:273.
4. Manetta A, MacNeill C, Lyter JA et al. Hexamethylmelamine as a single second line agent in ovarian cancer. Gynecol 1990;36:93.
5. Dembo AJ. Abdomino-pelvic radiotherapy in ovarian cancer: a ten-year experience. Cancer 1985;55:2285.
6. Martinez A, Schray MF, Howes AE. Postoperative radiation therapy for epithelial ovarian cancer: the curative role based on a twenty-four year experience. J Clin Oncol 1985;3:901.
7. Hacker NF, Berek JS, Burnison CM et al. Whole abdominal radiation as salvage therapy for epithelial ovarian cancer. Obstet Gynecol 1985:65:60.
8. Peters WA, Blasko JC, Bagley CM et al. Salvage therapy with whole abdominal irradiation in patients with advanced carcinoma of the ovary previously treated by combination chemotherapy. Cancer 1986;58:880.
9. Kersh CR, Randall ME, Constable WC et al. Whole abdominal radiation therapy following cytoreductive surgery and chemotherapy in ovarian carcinoma. Gynecol Oncol 1988;31:113.
10. Morgan L, Chafe W, Mendenhall W et al. Hypofractionation of whole abdomen radiation therapy: salvage treatment of persistent ovarian carcinoma following chemotherapy. Gynecol Oncol 1988; 31:122.
11. Haie C, Pejovic-Lafant MH, Georg M et al. Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma. Int J Radiat Oncol Biol Phys 1989;17:15.
12. Smith JP, Rudedge F. Chemotherapy and the treatment of cancer of the ovary. Am J Obstet Gynecol 1970;107:691.
13. Fuks Z. External radiotherapy of ovarian cancer: standard approaches and new frontiers. Semin Oncol 1975;2:253.
14. Fazekas JT, Maier JG. Irradiation of ovarian cancer: a prospective comparison of the open field and moving strip techniques. Am J Roentgenol Radium Ther Nucl Med 1974;120:118.
15. Piver MS, Barlow JJ, Lee FT et al. Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy, and radiation therapy. Am J Obstet Gynecol 1975; 122:355.
16. Cain JM, Russell AH, Greer BE et al. Whole abdomen radiation therapy for minimal residual epithelial ovarian carcinoma after surgical resection and maximum first line chemotherapy. Gynecol Oncol 1988;29:168.
17. Hainsworth JD, Malcolm A, Johnson DH et al. Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy. Obstet Gynecol 1983;61:619.
18. Hoskins WJ, Lichter AS, Whittington R et al. Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma. Gynecol Oncol 1985;20:271.
19. Kucera PR, Berman ML, Treadwell P et al. Whole abdominal radiotherapy for patients with minimal residual epithelial ovarian carcinoma. Gynecol Oncol 1990;36:338.
20. Rosen EM, Goldberg ID, Rose C et al. Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma. Radiother Oncol 1986;7:223.
21. Rizel S, Biran S, Anteby SO et al. Combined modality treatment for stage III ovarian carcinoma. Radiother Oncol 1985;3:237.
22. Schray MF, Martinez A, Howes AE et al. Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy. J Clin Oncol 1989;6:1433.
23. Steiner M, Rubinov R, Borovik R et al. Multimodal approach (surgery, chemotherapy, and radiotherapy) and the treatment of advanced ovarian carcinoma. Cancer 1985;55:2748.
24. Reddy S, Lee MD, Yordan E et al. Salvage whole abdomen radiation therapy: its role in ovarian cancer. Int J Radiat Oncol Biol Phys 1993;27:879.
25. Rubin P. Understanding the problem of understaging in ovarian cancer. Semin Oncol 1975;2:235.
26. Planner RS, Allen DG, Brand AH et al. Paclitaxel (Taxol) as salvage therapy for relapsed ovarian cancer. Aust NZJ Obstet Gynaecol 1996;36:168.
27. Formenti SC, Shrivastava PN, Sapozink M et al. Abdominopelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance, and pharmacology. Int J Radiat Oncol Biol Phys 1996;15:35:93.
28. Markman M, Iseminger KA, Hatch KD et al. Tamoxifen in platinum-refractory ovarian cancer: a gynecologic oncology group ancillary report. Gynecol Oncol 1996;62:4.
29. Narianaccio M, D'Daddario V, Serrati A et al. Leuprolide acetate as a salvage therapy and relapsed epithelial ovarian cancer. Eur J Gynaecol Oncol 1996;17:286.
30. Broun ER, Belinson JL, Berek JS et al. Salvage therapy for recurrent and refractory ovarian cancer with high dose chemotherapy and autologous bone marrow support: a gynecologic oncology group pilot study. Gynecol Oncol 1994;54:142.
31. Shpall EJ, Clarke-Pearson D, Soper JT et al. High dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III, IV epithelial ovarian cancer. Gynecol Oncol 1990;38:386.
32. Extra JM, Cure H, Viens P et al. High dose chemotherapy with autologous bone marrow transplantation in ovarian adenocarcinoma. Bull Cancer (Paris) 1993;80:156.
33. Stiff P, Bayer R, Camarda M et al. A phase II trial of high dose mitoxantrone, carboplatin, and cydophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome. Gynecol Oncol 1995; 57:278.
34. Benedetti-Panici P, Greggi S, Scambia G et al. Very high dose chemotherapy with autologous, peripheral stem cell support in advanced ovarian cancer. Eur J Cancer 1995;31A:1987.